1168PPhase I/II study of CTLA-4 inhibitor AGEN1884 + PD-1 Inhibitor AGEN2034 in patients with advanced/refractory solid tumors, with expansion into 2L cervical cancer and solid tumors.
Saved in:
| Title: | 1168PPhase I/II study of CTLA-4 inhibitor AGEN1884 + PD-1 Inhibitor AGEN2034 in patients with advanced/refractory solid tumors, with expansion into 2L cervical cancer and solid tumors. |
|---|---|
| Authors: | Coward, J1 (AUTHOR), Lemech, C2 (AUTHOR), Meniawy, T3 (AUTHOR), Dupont, C D4 (AUTHOR), Gonzalez, A M5 (AUTHOR), Lim, M6 (AUTHOR), Savitsky, D4 (AUTHOR), Carini, M7 (AUTHOR), Hu, S8 (AUTHOR), Shebanova, O9 (AUTHOR) |
| Source: | Annals of Oncology. 2018 Supplement, Vol. 29, pN.PAG-N.PAG. 1p. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!
